Anti-infective Agents : Antiretroviral Agents
OTRIU1 “Triumeq tablet”
Each tablet contains abacavir sulfate 50 mg, lamivudine 300 mg, dolutegravir 600 mg
適應症：適用於做為人類免疫不全病毒(HIV)感染症的完整治療藥物，適用的對象為未曾使用抗反轉錄病毒藥物治療，或所感染之HIV對Triumeq中的三種抗反轉錄病毒藥物不具已證實或臨床上疑似之抗藥性的成人患者及12歲以上的青少年患者。
Usual dose: 1 Tab QD with or without food.
Contraindication:
Dofetilide coadministration.
Moderate or severe (ie, Child-Pugh grade B or C) hepatic impairment.
Patients with the HLA-B*5701 allele.
Prior hypersensitivity reaction to abacavir, dolutegravir, or lamivudine.
Related Entries
(Visited 64 times, 1 visits today)